Published in Lancet on September 18, 1993
Mendelian Inheritance in Man and its online version, OMIM. Am J Hum Genet (2007) 9.61
SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet (2000) 3.58
A genome-wide association study for late-onset Alzheimer's disease using DNA pooling. BMC Med Genomics (2008) 2.20
Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect (2006) 1.94
Apolipoprotein E: risk factor for Alzheimer disease. Am J Hum Genet (1994) 1.83
Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials. Neuroimage (2012) 1.76
Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease. Proc Natl Acad Sci U S A (1994) 1.74
Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol (1996) 1.54
ApoE influences amyloid-β (Aβ) clearance despite minimal apoE/Aβ association in physiological conditions. Proc Natl Acad Sci U S A (2013) 1.50
Opposing effects of Apoe/Apoa1 double deletion on amyloid-β pathology and cognitive performance in APP mice. Brain (2015) 1.43
Genetic dissection of Alzheimer disease, a heterogeneous disorder. Proc Natl Acad Sci U S A (1995) 1.40
Exercise improves cognition and hippocampal plasticity in APOE epsilon4 mice. Alzheimers Dement (2009) 1.36
Apolipoprotein e4 allele and cognitive decline in elderly men. BMJ (1994) 1.31
Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet (1996) 1.30
Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study. BMJ (1994) 1.29
Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. Am J Pathol (1994) 1.28
Role of vascular risk factors and vascular dysfunction in Alzheimer's disease. Mt Sinai J Med (2010) 1.28
Brain regional quantification of F-ring and D-/E-ring isoprostanes and neuroprostanes in Alzheimer's disease. Am J Pathol (2001) 1.26
Neuropathology and apolipoprotein E profile of aged chimpanzees: implications for Alzheimer disease. Proc Natl Acad Sci U S A (1994) 1.22
Complete penetrance of Creutzfeldt-Jakob disease in Libyan Jews carrying the E200K mutation in the prion protein gene. Mol Med (1995) 1.19
Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people. Am J Epidemiol (2011) 1.19
The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients. Am J Pathol (1999) 1.12
Individualized quantification of brain β-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls. Eur J Nucl Med Mol Imaging (2011) 1.06
A population study of apoE genotype at the age of 85: relation to dementia, cerebrovascular disease, and mortality. J Neurol Neurosurg Psychiatry (1998) 1.02
The association of APOE genotype and cognitive decline in interaction with risk factors in a 65-69 year old community sample. BMC Geriatr (2008) 1.02
Mass spectrometric-based proteomic analysis of amyloid neuropathy type in nerve tissue. Arch Neurol (2010) 1.01
Antioxidant therapy in Alzheimer's disease: theory and practice. Mini Rev Med Chem (2008) 1.00
Apolipoprotein E polymorphisms and primary glaucoma in Saudis. Mol Vis (2009) 0.97
Is there a genetic basis for the deposition of beta-amyloid after fatal head injury? Cell Mol Neurobiol (1999) 0.96
Apolipoprotein E and Alzheimer's disease. Lancet (1993) 0.96
Human apolipoprotein E4 targeted replacement in mice reveals increased susceptibility to sleep disruption and intermittent hypoxia. Am J Physiol Regul Integr Comp Physiol (2012) 0.95
A population-based study of familial Alzheimer disease: linkage to chromosomes 14, 19, and 21. Am J Hum Genet (1994) 0.94
Olfaction in aging and Alzheimer's disease: event-related potentials to a cross-modal odor-recognition memory task discriminate ApoE epsilon4+ and ApoE epsilon 4- individuals. Ann N Y Acad Sci (2009) 0.93
Human prions and plasma lipoproteins. Proc Natl Acad Sci U S A (2006) 0.93
ApoE isoform-specific regulation of regeneration in the peripheral nervous system. Hum Mol Genet (2011) 0.93
A SAGE study of apolipoprotein E3/3, E3/4 and E4/4 allele-specific gene expression in hippocampus in Alzheimer disease. Mol Cell Neurosci (2007) 0.92
Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer beta-amyloid deposition. Acta Neuropathol (1994) 0.91
PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease. J Cell Mol Med (2009) 0.90
Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS One (2012) 0.90
Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice. Am J Pathol (1998) 0.89
Genetic cross-interaction between APOE and PRNP in sporadic Alzheimer's and Creutzfeldt-Jakob diseases. PLoS One (2011) 0.89
Exercise, APOE genotype, and the evolution of the human lifespan. Trends Neurosci (2014) 0.89
Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol (1994) 0.88
The apolipoprotein E allele epsilon 4 does not correlate with the number of senile plaques or neurofibrillary tangles in patients with Alzheimer's disease. J Neurol Neurosurg Psychiatry (1996) 0.88
Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. J Neurosci (2008) 0.87
Candidate genes and risk for CP: a population-based study. Pediatr Res (2011) 0.87
Molecular pathogenesis of Alzheimer's disease: reductionist versus expansionist approaches. Int J Mol Sci (2009) 0.87
ApoE gene polymorphism and vascular dementia in Chinese population: a meta-analysis. J Neural Transm (Vienna) (2011) 0.86
Genotype-phenotype interactions in pediatric obstructive sleep apnea. Respir Physiol Neurobiol (2013) 0.85
Apolipoproteins E and C1 and brain morphology in memory impaired elders. Neurogenetics (2002) 0.85
Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients. J Neural Transm (Vienna) (2005) 0.85
Imaging the Alzheimer brain. J Alzheimers Dis (2011) 0.83
Hippocampal infusions of apolipoprotein E peptides induce long-lasting cognitive impairment. Brain Res Bull (2009) 0.82
Functional connectivity during recognition memory in individuals genetically at risk for Alzheimer's disease. Hum Brain Mapp (2011) 0.82
MRI-based brain atrophy rates in ADNI phase 2: acceleration and enrichment considerations for clinical trials. Neurobiol Aging (2015) 0.82
Neuroprotection and neurodegeneration in Alzheimer's disease: role of cardiovascular disease risk factors, implications for dementia rates, and prevention with aerobic exercise in african americans. Int J Alzheimers Dis (2012) 0.81
Genomics of Dementia: APOE- and CYP2D6-Related Pharmacogenetics. Int J Alzheimers Dis (2012) 0.81
Reduced hippocampal activity during encoding in cognitively normal adults carrying the APOE ɛ4 allele. Neuropsychologia (2011) 0.81
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci (2011) 0.81
Hippocampal infusions of MARCKS peptides impair memory of rats on the radial-arm maze. Brain Res (2009) 0.81
Association of leisure-time physical activity with cognition by apolipoprotein-E genotype in persons aged 60 years and over: the National Health and Nutrition Examination Survey (NHANES-III). Clin Interv Aging (2012) 0.80
Eradication of Helicobacter pylori Is Associated with the Progression of Dementia: A Population-Based Study. Gastroenterol Res Pract (2013) 0.80
Integrative analysis of common neurodegenerative diseases using gene association, interaction networks and mRNA expression data. AMIA Jt Summits Transl Sci Proc (2012) 0.79
Effects of apoE deficiency and occlusal disharmony on amyloid-beta production and spatial memory in rats. PLoS One (2013) 0.78
Aggravated decrease in the activity of nucleus basalis neurons in Alzheimer's disease is apolipoprotein E-type dependent. Proc Natl Acad Sci U S A (1998) 0.78
Genetic variants conferring susceptibility to Alzheimer's disease in the general population; do they also predispose to dementia in Down's syndrome. BMC Res Notes (2014) 0.78
Association of apolipoprotein epsilon 4 allele and neuropathologic findings in patients with dementia. Acta Neuropathol (1995) 0.78
APOE ε2 and ε4 influence the susceptibility for Alzheimer's disease but not other dementias. Int J Mol Epidemiol Genet (2010) 0.77
Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's disease. J Neural Transm (Vienna) (2006) 0.77
Bioactive TGF-beta can associate with lipoproteins and is enriched in those containing apolipoprotein E3. J Neurochem (2009) 0.77
Interaction between years of education and APOE ε4 status on frontal and temporal metabolism. Neurology (2015) 0.76
Potential natural products for Alzheimer's disease: targeted search using the internal ribosome entry site of tau and amyloid-β precursor protein. Int J Mol Sci (2015) 0.76
Apolipoprotein E epsilon 4 allele distribution in Wernicke-Korsakoff syndrome with or without global intellectual deficits. J Neural Transm (Vienna) (1997) 0.76
APOE ϵ4, rated life experiences, and affect among centenarians. Aging Ment Health (2013) 0.75
Aluminum and Alzheimer's disease. CMAJ (1995) 0.75
ABCA1 Deficiency Affects Basal Cognitive Deficits and Dendritic Density in Mice. J Alzheimers Dis (2017) 0.75
Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease. Acta Neuropathol (1995) 0.75
Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science (1987) 6.89
Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 5.68
Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci U S A (1993) 4.86
Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry (2000) 4.23
A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease. Science (1991) 4.09
Environment and development. Earth system science for global sustainability: grand challenges. Science (2010) 3.92
Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet (1999) 3.82
Documented head injury in early adulthood and risk of Alzheimer's disease and other dementias. Neurology (2000) 3.61
Specificity, sensitivity, and predictive value of apolipoprotein-E genotyping for sporadic Alzheimer's disease. Lancet (1996) 3.58
Insoluble detergent-resistant aggregates form between pathological and nonpathological lengths of polyglutamine in mammalian cells. Proc Natl Acad Sci U S A (1999) 3.33
Localization of amyloid beta protein messenger RNA in brains from patients with Alzheimer's disease. Science (1987) 3.07
Mutations in familial Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker's syndrome. Exp Neurol (1989) 3.00
Foetal thymic transplant in a case of Digeorge's syndrome. Lancet (1968) 2.85
MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1. J Biol Chem (2000) 2.83
Analysis of neocortex in three males with the fragile X syndrome. Am J Med Genet (1991) 2.70
Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. Int J Geriatr Psychiatry (2001) 2.63
Transmissible familial Creutzfeldt-Jakob disease associated with five, seven, and eight extra octapeptide coding repeats in the PRNP gene. Proc Natl Acad Sci U S A (1991) 2.55
Evidence of founder chromosomes in fragile X syndrome. Nat Genet (1992) 2.38
A complex mutable polymorphism located within the fragile X gene. Nat Genet (1993) 2.33
Role of the alpha2-integrin in osteoblast-specific gene expression and activation of the Osf2 transcription factor. J Biol Chem (1998) 2.26
Direct sequencing of the gene for Maryland/German familial amyloidotic polyneuropathy type II and genotyping by allele-specific enzymatic amplification. Genomics (1989) 2.17
Comparing proxy and patients' perceptions of patients' functional status: results from an outpatient geriatric clinic. J Am Geriatr Soc (1992) 2.16
Characteristics of nonresponders in a community survey of the elderly. J Am Geriatr Soc (1994) 2.05
APOE genotype predicts when--not whether--one is predisposed to develop Alzheimer disease. Nat Genet (1998) 2.05
Alzheimer's disease in the NAS-NRC Registry of aging twin veterans, IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med (1995) 2.01
Prevalence of depression and its treatment in an elderly population: the Cache County study. Arch Gen Psychiatry (2000) 1.97
Familial amyloidotic polyneuropathy. Trends Neurosci (1989) 1.89
Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry (1986) 1.80
Adult fragile X syndrome. Clinico-neuropathologic findings. Acta Neuropathol (1985) 1.80
Intracellular ferritin accumulation in neural and extraneural tissue characterizes a neurodegenerative disease associated with a mutation in the ferritin light polypeptide gene. J Neuropathol Exp Neurol (2004) 1.76
An evidence-based proposal for the classification of neuropsychiatric disturbance in Alzheimer's disease. Int J Geriatr Psychiatry (2001) 1.75
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics (1990) 1.74
Primary structure of an amyloid prealbumin and its plasma precursor in a heredofamilial polyneuropathy of Swedish origin. Proc Natl Acad Sci U S A (1984) 1.74
Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum Mol Genet (1997) 1.70
Autocrine induction of collagenase by serum amyloid A-like and beta 2-microglobulin-like proteins. Science (1989) 1.69
The protofilament substructure of amyloid fibrils. J Mol Biol (2000) 1.69
C-reactive protein and the acute-phase response. J Lab Clin Med (1981) 1.67
Beta amyloid gene duplication in Alzheimer's disease and karyotypically normal Down syndrome. Science (1987) 1.67
Chromosome 14-encoded Alzheimer's disease: genetic and clinicopathological description. Ann Neurol (1994) 1.64
Hereditary influences on cognitive functioning in older men. A study of 4000 twin pairs. Arch Neurol (1993) 1.62
Fragile X gene instability: anchoring AGGs and linked microsatellites. Am J Hum Genet (1995) 1.61
Polymorphism of human plasma thyroxine binding prealbumin. Biochem Biophys Res Commun (1983) 1.60
Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1. Amyloid (1999) 1.59
Inheritance of mitral valve prolapse: effect of age and sex on gene expression. Ann Intern Med (1982) 1.58
Weight change in Alzheimer's disease. J Am Geriatr Soc (1996) 1.57
Fragile X and autism: a multicenter survey. Am J Med Genet (1986) 1.56
Detection of full fragile X mutation. Lancet (1992) 1.55
Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum (1979) 1.53
Familial transmission of the FMR1 CGG repeat. Am J Hum Genet (1996) 1.53
Congenital webs, cysts, laryngoceles and other anomalies of the larynx. Ann Otol Rhinol Laryngol (1967) 1.51
Intelligence and education as predictors of cognitive state in late life: a 50-year follow-up. Neurology (1995) 1.50
Staphylococcus aureus bacteremia among elderly vs younger adult patients: comparison of clinical features and mortality. Arch Intern Med (1999) 1.49
Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome. Am J Hum Genet (1993) 1.47
Apolipoprotein E epsilon 4 allele and hippocampal volume in twins with normal cognition. Neurology (1997) 1.47
Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. J Am Geriatr Soc (1999) 1.47
The FRAXE Syndrome: is it time for routine screening? Am J Hum Genet (1996) 1.46
Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46
"A" protein of amyloidosis. Isolation of a cross-reacting component from serum by affinity chromatography. Arthritis Rheum (1975) 1.46
Postnatal confirmation of prenatally diagnosed trisomy 16 mosaicism in two phenotypically abnormal liveborns. Prenat Diagn (1994) 1.46
New hemorrhagic fever with renal syndrome-related virus in rodents in the United States. Lancet (1982) 1.46
Rapid brain autopsy. The Joseph and Kathleen Bryan Alzheimer's Disease Research Center experience. Arch Pathol Lab Med (1997) 1.46
Lack of association of a restriction fragment length polymorphism for serum amyloid P gene with reactive amyloidosis. Arthritis Rheum (1989) 1.45
Kinetics of serum amyloid protein A in casein-induced murine amyloidosis. J Clin Invest (1977) 1.45
Recent advances in the genetics of Alzheimer's disease and vascular dementia with an emphasis on gene-environment interactions. J Am Geriatr Soc (1996) 1.44
Dementia diagnoses from clinical and neuropsychological data compared: the Cache County study. Neurology (2000) 1.44
Stress and well-being in mothers of young children 11 years after the Chornobyl nuclear power plant accident. Psychol Med (2002) 1.44
Synthesis and secretion of serum amyloid protein A (SAA) by hepatocytes in mice treated with casein. J Immunol (1980) 1.44
Smoking, Alzheimer's disease, and confounding with genes. Lancet (1995) 1.43
Differential regulation of amyloid-beta-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer disease. Proc Natl Acad Sci U S A (1988) 1.43
Partial characterization of Prospect Hill virus isolated from meadow voles in the United States. J Infect Dis (1985) 1.42
The x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolution. J Biol Chem (1993) 1.42
Distinct muscle imaging patterns in myofibrillar myopathies. Neurology (2008) 1.41
Partial amino acid sequence homology between an heredofamilial amyloid protein and human plasma prealbumin. J Clin Invest (1981) 1.41
FRAXAC1 and DXS548 polymorphisms in the Chinese population. Am J Med Genet (1999) 1.41
Amyloidosis of the shoulder in patients on chronic hemodialysis: sonographic findings. AJR Am J Roentgenol (1996) 1.41
Late-onset muscle weakness in partial phosphofructokinase deficiency: a unique myopathy with vacuoles, abnormal mitochondria, and absence of the common exon 5/intron 5 junction point mutation. Neurology (1996) 1.39
A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol Psychiatry (1997) 1.39
Isolation and identification by sequence analysis of experimentally induced guinea pig amyloid fibrils. J Exp Med (1974) 1.39
Biochemical and molecular genetic characterization of a new variant prealbumin associated with hereditary amyloidosis. J Clin Invest (1986) 1.38
Molecular and clinical correlations in spinocerebellar ataxia type I: evidence for familial effects on the age at onset. Am J Hum Genet (1994) 1.38
Murine amyloid protein AA in casein-induced experimental amyloidosis. Lab Invest (1977) 1.35
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun (1988) 1.35
Transthyretin: a review from a structural perspective. Cell Mol Life Sci (2001) 1.34
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: the Cache County study. Neurology (2000) 1.33
Enhanced green fluorescent protein as a marker for localizing murine cytomegalovirus in acute and latent infection. J Virol Methods (2000) 1.33
Fmr1 knockout mouse has a distinctive strain-specific learning impairment. Neuroscience (2000) 1.32
Localization of the human prealbumin gene to chromosome 18. Biochem Biophys Res Commun (1985) 1.32
The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis. J Am Geriatr Soc (1998) 1.32
Guidelines for the diagnosis of fragile X syndrome. National Fragile X Foundation. J Med Genet (1993) 1.30
Cooperation between carrier-reactive and hapten-sensitive cells in vitro. Nat New Biol (1971) 1.30
Treatment of Wegener's granulomatosis with immunosuppressive agents. Description of renal ultrastructure. Arch Intern Med (1970) 1.29
Amyloid beta-protein inhibits ubiquitin-dependent protein degradation in vitro. J Biol Chem (1995) 1.28
Isolation and propagation of nephropathia epidemica virus in bank voles. Scand J Infect Dis (1984) 1.26
Familial Alzheimer Dementia: a prevalent disorder with specific clinical features. Psychol Med (1984) 1.24
Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis. Arthritis Rheum (1983) 1.23
Mosaicism in fragile X affected males. Am J Med Genet (1994) 1.23
Characterization of a transthyretin (prealbumin) variant associated with familial amyloidotic polyneuropathy type II (Indiana/Swiss). J Clin Invest (1986) 1.23
Children's well-being 11 years after the Chornobyl catastrophe. Arch Gen Psychiatry (2000) 1.22
Localization of the ankyrin-binding site on erythrocyte membrane protein, band 3. J Biol Chem (1989) 1.21